2seventy bio Inc.

NASDAQ: TSVT · Real-Time Price · USD
5.00
0.00 (0.00%)
At close: May 12, 2025, 3:59 PM

2seventy bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
22.94M 2.93M 13.53M 8.97M 12.44M 10.68M 12.03M 36.05M 41.62M 56.18M 13.41M 13.48M 8.43M 16.03M 19.26M 7.33M 11.9M
Cost of Revenue
5.15M 8.84M 5.77M 3.45M 6.61M 6.18M 4.96M 4.52M 4.29M 15.32M 377K 4.65M 5.86M 405K 320K 10.16M 1.7M
Gross Profit
17.79M -5.92M 7.77M 5.51M 5.83M 4.51M 7.08M 31.53M 37.33M 40.85M 13.03M 8.83M 2.57M 15.63M 18.94M -2.83M 10.2M
Operating Income
-2.52M -23.27M -13.94M -20.36M -48.65M -59.88M -77.97M -47.99M -51.64M -27.16M -68.32M -76.89M -90.54M -68.37M -65.24M -87.97M -92.37M
Interest Income
2.32M 2.63M 2.85M 2.53M 2.86M 3.65M 3.63M 3.09M 2.05M 1.49M 1.11M 213K 115K 88K n/a n/a n/a
Pretax Income
482K -19.52M -9.93M 24.88M -52.67M -56.82M -71.64M -42.09M -47.02M -23.16M -67.88M -77.4M -85.71M -60.97M -60M -84.04M -87.2M
Net Income
482K -19.52M -9.93M 24.88M -52.67M -56.82M -71.64M -42.09M -42.48M -23.14M -67.44M -77.42M -80.93M -60.97M -60M -84.04M -87.2M
Selling & General & Admin
14.85M 8.52M 12.88M 9.86M 12.66M 16.2M 13M 19.49M 20.72M 18.7M 19.61M 17.28M 23.86M 24.48M 23M 21.4M 24.63M
Research & Development
5.4M 8.65M 8.32M 16.01M 41.82M 48.19M 51.31M 59.98M 68.25M 49.31M 61.74M 68.44M 69.25M 59.54M 61.13M 63.69M 77.57M
Other Expenses
57K 172K 503K n/a n/a -534K n/a n/a n/a n/a -624K -644K n/a n/a n/a n/a n/a
Operating Expenses
20.3M 17.35M 21.71M 24.19M 54.48M 64.39M 64.32M 79.47M 88.97M 68.01M 81.35M 85.72M 93.11M 84.02M 84.13M 85.09M 102.2M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
25.46M 26.19M 27.48M 29.32M 61.09M 70.56M 69.28M 83.99M 93.26M 83.34M 81.73M 90.37M 98.97M 84.43M 84.45M 95.25M 103.9M
Income Tax Expense
n/a n/a n/a n/a n/a n/a 17.1M n/a -4.55M -17K -439K 17K -4.78M -3.65M 48K 47K 369K
Shares Outstanding (Basic)
53.05M 52.33M 52.26M 52.19M 52.07M 51.38M 51.18M 50.97M 43.47M 38.68M 38.57M 38.38M 26.75M 23.59M 23.29M 23.29M 23.29M
Shares Outstanding (Diluted)
53.43M 52.33M 52.26M 55.01M 52.07M 51.38M 51.18M 50.97M 43.47M 38.68M 38.57M 38.38M 26.75M 23.88M 23.29M 23.29M 23.29M
EPS (Basic)
0.01 -0.37 -0.19 0.48 -1.01 -1.11 -1.4 -0.83 -0.98 -0.6 -1.75 -2.02 -3.03 -2.59 -2.58 -3.61 -3.74
EPS (Diluted)
0.01 -0.37 -0.19 0.45 -1.01 -1.11 -1.4 -0.83 -0.98 -0.6 -1.75 -2.02 -3.03 -2.55 -2.58 -3.61 -3.74
EBITDA
-825K -21.44M -11.78M -18.68M -46.55M -56.85M -54.48M -45.7M -49.38M -24.84M -65.94M -73.59M -87.01M -64.86M -60.52M -83.45M -88.33M
EBIT
-2.46M -23.09M -13.44M -20.36M -48.65M -59.88M -57.24M -47.94M -51.64M -27.16M -68.32M -76.89M -90.54M -68.4M -65.19M -87.92M -92M
Depreciation & Amortization
1.64M 1.66M 1.66M 1.68M 2.11M 3.03M 2.76M 2.24M 2.25M 2.33M 2.38M 3.3M 3.53M 3.54M 4.67M 4.47M 3.68M